The Lynx Group has merged with Amplity Health
Mergers & Acquisitions
|Client & Transactional Partners||
The Lynx Group
Altamont Capital Partners
The Lynx Group, an award-winning medical communications company specializing in oncology and complex drugs, has merged with Amplity Health, a leading global medical and commercial partner to biopharmaceutical companies. The transformational combination of Amplity and Lynx creates a differentiated scale player that offers comprehensive medical and commercial solutions to clients and the patients they serve.
Cain Brothers, a division of KeyBanc Capital Markets, served as exclusive financial advisor to The Lynx Group in connection with the transaction. The Lynx Group engaged Cain Brothers based on its deep expertise in the pharma services space, its highly relevant transaction track record and its extensive relationships with the potential strategic and financial buyer universe.
Amplity Health provides unique and transformational solutions to global healthcare companies around the world. It continually challenges the boundaries of medical and commercial strategies to improve the lives of patients. Amplity has the expertise, infrastructure and data-driven insights to help clients overcome any healthcare commercialization hurdle. Amplity’s wide-ranging capabilities include clinical and medical outsourced teams, remote and field sales solutions, capabilities development and consulting. Amplity’s one-of-a-kind Insights database offers clients a detailed view into patient-provider interactions and provider treatment rationale not found through any other provider.
Altamont Capital Partners is a private investment firm based in the San Francisco Bay Area with more than $3.5 billion of assets under management. Altamont is focused on investing in middle market businesses where it can partner with leading management teams to help its portfolio companies reach their full potential. The firm’s principals have significant experience in a range of industries, including business services, financial services, healthcare, consumer/retail and industrials.
The Lynx Group is a premier medical communications and education company acutely focused on oncology and rare disease states. Lynx specializes in market access to and with advanced practice providers, patients, and their caregivers. With more than 100 years of combined senior leadership experience, Lynx continually creates award-winning medical education and cultivates strong relationships within proprietary brands serving patients and their caregivers, physicians, payers, nurses, pharmacists, navigators and practice managers. Currently, Lynx partners with more than 50 of the top pharma and biotech companies globally.